Results 31 to 40 of about 1,021 (141)
Evolution of reticular pseudodrusen [PDF]
British Journal of Ophthalmology, 2010 To report observations relating to the clinical recognition and possible basis of reticular pseudodrusen (RPD).This retrospective study reports the evolution of RPD in 166 patients who had follow-up of over 1 year using multiple imaging techniques. Mean age when first seen was 73.3 years and the mean period of observation was 4.9 years (range 1-18 ...
John, Sarks +4 more
openaire +2 more sources
PLoS ONE, 2021 PurposeTo evaluate the incidence and risk factors of neovascularization in unaffected fellow eyes of patients diagnosed with type 3 neovascularization in Korea.MethodsThis retrospective study included 93 unaffected fellow eyes of 93 patients diagnosed ...
Jae Hyuck Kwak +5 more
doaj +1 more source
Frontiers in Medicine, 2021 Age-related macular degeneration (AMD) is characterized by the accumulation of debris in the posterior eye. In this study we evaluated peripheral blood monocyte phagocytic function at various stages of AMD and in aged matched control participants.
Ben J. Gu +15 more
doaj +1 more source
The Relationship Between Reticular Pseudodrusen and Severity of AMD. [PDF]
Ophthalmology, 2016 Kovach JL +7 more
europepmc +4 more sources
Deep Learning Automated Detection of Reticular Pseudodrusen from Fundus Autofluorescence Images or Color Fundus Photographs in AREDS2 [PDF]
Ophthalmology, 2020 Yifan Peng +2 more
exaly +2 more sources
Acta Ophthalmologica, Volume 101, Issue 8, Page 881-890, December 2023., 2023 Abstract Geographic atrophy (GA) secondary to age‐related macular degeneration is among the most common causes of irreversible vision loss in industrialized countries. Recently, two therapies have been approved by the US FDA. However, given the nature of their treatment effect, which primarily involves a relative decrease in disease progression ...
Maximilian Pfau +5 more
wiley +1 more source
Treatment of dry age‐related macular degeneration: A review
Clinical &Experimental Ophthalmology, Volume 51, Issue 8, Page 835-852, November 2023., 2023 Abstract Age‐related macular degeneration is a global disease with a significant societal impact. The advent of anti‐vascular endothelial growth factor therapy (anti‐VEGF) has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD).
Shenouda Girgis, Lawrence R. Lee
wiley +1 more source
Optometrists' attitudes toward using OCT angiography lag behind other retinal imaging types
Ophthalmic and Physiological Optics, Volume 43, Issue 4, Page 905-915, July 2023., 2023 Abstract Purpose While optometrists' attitudes toward established retinal imaging types are generally positive, they are unknown for optical coherence tomography angiography (OCTA). We performed a cross‐sectional survey to estimate attitudes toward OCTA and identify clinician and/or practice characteristics that influence them.
Rene Cheung, Sharon Ho, Angelica Ly
wiley +1 more source
Acta Ophthalmologica, Volume 101, Issue 2, Page e135-e142, March 2023., 2023 Abstract Purpose The aim of the present study was to determine whether microperimetric parameters could predict the progression of an eye at high risk of age‐related macular degeneration (AMD) at 24 months. Methods We conducted a multicentric prospective non‐comparative open‐label study including patients with one eye in stage 4 of the Age‐Related Eye ...
Laurent Kodjikian +9 more
wiley +1 more source
Subretinal drusenoid deposits: An update
Taiwan Journal of Ophthalmology, 2022 A wide spectrum of phenotypic manifestations characterizes age-related macular degeneration (AMD). Drusen is considered the hallmark of AMD and is located underneath the retinal pigment epithelium (RPE). In contrast, subretinal drusenoid deposits (SDDs),
Manuel Monge, Adriana Araya, Lihteh Wu
doaj +1 more source